Party drug tested to calm cancer anxiety
NCT ID NCT05086250
Summary
This small early study is testing whether oral ketamine (a medication sometimes used for depression) can help reduce anxiety in people with pancreatic cancer. Twenty participants will try both ketamine and a placebo pill in random order to see if it's safe and tolerable. The main goal is to see if this type of study is practical to run, while also checking if ketamine affects anxiety, mood, pain, and sleep.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cedars-Sinai Medical Center
RECRUITINGLos Angeles, California, 90048, United States
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.